1. Home
  2. RAPT vs AMBQ Comparison

RAPT vs AMBQ Comparison

Compare RAPT & AMBQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RAPT Therapeutics Inc.

RAPT

RAPT Therapeutics Inc.

HOLD

Current Price

$35.10

Market Cap

498.4M

Sector

Health Care

ML Signal

HOLD

AMBQ

Ambiq Micro Inc.

N/A

Current Price

$29.50

Market Cap

533.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RAPT
AMBQ
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
498.4M
533.3M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
RAPT
AMBQ
Price
$35.10
$29.50
Analyst Decision
Strong Buy
Buy
Analyst Count
10
4
Target Price
$57.00
$41.75
AVG Volume (30 Days)
433.7K
83.4K
Earning Date
11-06-2025
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$72,109,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.03
52 Week Low
$5.67
$22.12
52 Week High
$42.39
$51.76

Technical Indicators

Market Signals
Indicator
RAPT
AMBQ
Relative Strength Index (RSI) 56.26 N/A
Support Level $34.38 N/A
Resistance Level $36.92 N/A
Average True Range (ATR) 2.56 0.00
MACD -0.11 0.00
Stochastic Oscillator 50.37 0.00

Price Performance

Historical Comparison
RAPT
AMBQ

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About AMBQ Ambiq Micro Inc.

Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.

Share on Social Networks: